Table 2.
Odds Ratios and Associated 95% Confidence Intervals of Being the Top 10% of the Total Hospital Costs in the Following Year (n=9624)
| Characteristics | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | Model 7 | Model 8 |
|---|---|---|---|---|---|---|---|---|
| Age | 1.02 (1.01–1.02)** | 1.01 (1.01–1.02)** | 1.01 (1.01–1.02)** | 1.01 (1.01–1.02)** | 1.01 (1.01–1.02)** | 1.01 (1.00–1.02)** | 1.01 (1.00–1.02)** | 1.01 (1.00–1.02)** |
| Gender | ||||||||
| Males | - | - | - | - | - | - | - | - |
| Females | 1.17 (1.02–1.34)* | 1.17 (1.02–1.34)* | 1.20 (1.05–1.38)** | 0.98 (0.86–1.13) | 1.20 (1.04–1.37)* | 0.99 (0.86–1.15) | 1.02 (0.88–1.17) | 1.02 (0.88–1.17) |
| Race ethnicities | ||||||||
| White Non-Hispanic | - | - | - | - | - | - | - | - |
| Black Non-Hispanic | 0.81 (0.70–0.95)** | 0.79 (0.68–0.92)** | 0.81 (0.69–0.94)** | 0.83 (0.71–0.96)* | 0.80 (0.69–0.94)** | 0.82 (0.70–0.95)* | 0.81 (0.69–0.95)* | 0.81 (0.70–0.95)* |
| Other Non-Hispanic | 0.54 (0.38–0.77)** | 0.59 (0.42–0.84)** | 0.60 (0.42–0.86)** | 0.53 (0.37–0.75)** | 0.60 (0.42–0.86)** | 0.55 (0.39–0.78)** | 0.55 (0.38–0.78)** | 0.55 (0.38–0.78)** |
| Hispanic Any Race | 1.10 (0.72–1.69) | 1.14 (0.74–1.76) | 1.15 (0.74–1.77) | 0.94 (0.60–1.46) | 1.14 (0.74–1.77) | 0.95 (0.61–1.49) | 0.95 (0.61–1.49) | 0.95 (0.61–1.49) |
| Panels | ||||||||
| 2012 – 2013 | - | - | - | - | - | - | - | - |
| 2011 – 2012 | 1.00 (0.85–1.19) | 0.99 (0.83–1.16) | 1.02 (0.86–1.21) | 0.99 (0.84–1.18) | 1.02 (0.86–1.21) | 1.00 (0.84–1.18) | 1.00 (0.84–1.18) | 1.00 (0.84–1.18) |
| 2010 – 2011 | 1.00 (0.85–1.17) | 0.99 (0.85–1.17) | 1.04 (0.89–1.22) | 1.00 (0.85–1.18) | 1.04 (0.89–1.22) | 1.01 (0.86–1.19) | 1.02 (0.87–1.20) | 1.02 (0.87–1.20) |
| Number of chronic conditions (year 1) | 1.22 (1.16–1.29)** | 1.11 (0.93–1.33) | 1.08 (1.02–1.14)** | 0.98 (0.82–1.18) | ||||
| Top 10 chronic conditions (year 1) | ||||||||
| Mental health problems | 1.07 (0.93–1.24) | 0.97 (0.77–1.22) | 0.97 (0.84–1.13) | 0.99 (0.79–1.25) | ||||
| Hypertension | 1.24 (1.07–1.44)** | 1.12 (0.88–1.42) | 1.04 (0.89–1.22) | 1.07 (0.84–1.36) | ||||
| Diabetes | 0.95 (0.81–1.11) | 0.86 (0.68–1.08) | 0.98 (0.83–1.15) | 0.99 (0.79–1.26) | ||||
| COPD/Asthma | 1.11 (0.93–1.32) | 0.94 (0.68–1.31) | 1.03 (0.86–1.23) | 1.06 (0.76–1.42) | ||||
| Coronary artery disease/ MI | 1.53 (1.25–1.89)** | 1.38 (1.05–1.82)* | 1.24 (1.00–1.53) | 1.26 (0.96–1.66) | ||||
| Liver disease | 1.60 (1.24–1.89)** | 1.42 (1.02–1.97)* | 1.27 (0.98–1.66) | 1.30 (0.93–1.82) | ||||
| Cancer | 1.77 (1.36–2.31)** | 1.58 (1.14–2.19)** | 1.17 (0.88–1.54) | 1.19 (0.85–1.67) | ||||
| Heart disease | 1.42 (1.05–1.91)* | 1.28 (0.90–1.81) | 1.32 (0.98–1.79) | 1.35 (0.95–1.66) | ||||
| Cerebrovascular disease | 1.10 (0.74–1.65) | 0.98 (0.62–1.54) | 0.92 (0.61–1.39) | 0.94 (0.59–1.49) | ||||
| Congestive heart failure | 2.30 (1.63–3.26)** | 2.07 (1.41–3.07)** | 2.24 (1.56–3.20)** | 2.28 (1.53–3.40)** | ||||
| Total hospital visits (year 1) | 1.14 (1.12–1.16)** | 1.13 (1.11–1.15)** | 1.13 (1.11–1.15)** | 1.13 (1.11–1.15)** | ||||
| Number of prescription drugs (year1) | ||||||||
| 0 | - | - | - | - | ||||
| 1–2 | 1.29 (1.01–1.63)* | 1.27 (1.00–1.62)* | 1.32 (1.04–1.68)* | 1.32 (1.04–1.68)* | ||||
| 3–5 | 1.23 (0.99–1.52) | 1.20 (0.97–1.49) | 1.25 (1.01–1.55)* | 1.25 (1.01–1.55)* | ||||
| 6 or more | 1.53 (1.25–1.86)** | 1.51 (1.24–1.84)** | 1.55 (1.27–1.90)** | 1.55 (1.27–1.90)** | ||||
p<0.05;
p<0.01
Model 1: age, age quadratic term, gender, race and panel indicator
Model 2: Model 1 + number of chronic conditions
Model 3: Model 1 + 10 most prevalent chronic conditions
Model 4: Model 1 + health utilization variables
Model 5: Model 1 + number of chronic conditions + 10 most prevalent chronic conditions
Model 6: Model 1 + number of chronic conditions + health utilization variables
Model 7: Model 1 + 10 most prevalent chronic conditions + health utilization variables
Model 8: Model 1 + number of chronic conditions + 10 most prevalent chronic conditions + health utilization variables